Pyronaridine - artesunate

DRUG3 trials

Sponsors

Medicines for Malaria Venture, Strathmore University

Conditions

Falciparum MalariaMalariaMalaria Falciparum

Phase 3

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

CompletedNCT00403260

Medicines for Malaria VentureFalciparum Malaria

Start: 2007-01-31End: 2008-12-31Updated: 2021-11-02

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

TerminatedNCT04368910

Medicines for Malaria VentureMalaria

Start: 2007-09-06End: 2010-11-15Updated: 2022-01-26

Unknown Phase

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

CompletedNCT07362498

Strathmore UniversityMalaria Falciparum

Start: 2020-06-01End: 2024-01-31Updated: 2026-01-23

Related Papers

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients

Antimicrobial Agents and Chemotherapy2015-12-1536 citations

Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.

2013-02-2158 citations

Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.

2012-04-0167 citations